Navigation Links
Creekridge Capital Continues Vendor Growth within Technology
Date:2/26/2013

MINNEAPOLIS, Feb. 26, 2013 /PRNewswire/ -- Creekridge Capital, a nationwide independent vendor leasing company providing third party and total private label programs to healthcare and technology manufacturers, continues its momentum in the technology industry by signing a formal vendor agreement and implementing a leasing program with Comm-Works, a leading technology company within the integration and support niche.

(Logo: http://photos.prnewswire.com/prnh/20130226/CG64874LOGO)

Comm-Works and Creekridge Capital partnered to provide financial solutions under the private label name, Comm-Works Capital.  Comm-Works provides high-quality technology solutions to clients across the nation and globe, including many Fortune 500 companies.  Their complete technology solutions include infrastructure, interaction, security and cost-saving energy management.  Comm-Works has experience providing technology solutions for companies across several industries.

"We are very excited Comm-Works has chosen to partner with us.  We look forward to executing a strategic program to help Comm-Works remain at the top of their industry.  Our private label offering of financial solutions to the technology industry is second to none," stated Bob John , vice president of technology and cloud financing. 

About Comm-Works
Leveraging its broad industry knowledge and global reach, Comm-Works acts as an extension of its clients to deliver scalable, consistent and high-quality technology solutions.  Founded in 1995, Minneapolis-based Comm-Works provides LimITless Possibilities(SM) to organizations with an extensive array of technology needs, no matter what, when or where it's needed.  Learn more at www.comm-works.com.

About Creekridge Capital
Creekridge Capital is an independent source of capital providing creative vendor leasing solutions primarily to the healthcare and technology industries.  Based in Minneapolis, the company has offices throughout the United States.  More information is available at www.creekridgecapital.com.

Contact:

 

Jeff Cowan

Co-CEO

Creekridge Capital

Phone:

(952) 996-0270


'/>"/>
SOURCE Creekridge Capital
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Foundation Venture Capital Group Commits Second Round of Funding to Actinobac Biomed
2. Abaxis to Present at Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference
3. Frost & Sullivan: Clinical Trial-based Evidence Vital to Obtain Venture Capital Funding for Wireless Patient Monitoring Technologies
4. Physicians Capital Investments Receives "Outstanding Development Award" for Sandy, Oregon Project
5. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
6. Shares of Oramed Pharmaceuticals Are Approved for Listing on the Nasdaq Capital Market
7. Life Sciences Venture Capital Funding Drops 14% During 2012, According To The MoneyTree Report
8. Linden Capital Partners Completes Acquisition of Young Innovations, Inc.
9. CytoSorbents Receives Approximately $400,000 in Non-Dilutive Capital from the Sale of Net Operating Loss Carryovers
10. Foundation Venture Capital Group Invests In Start-Up Working to Reduce Side Effects of Parkinsons Treatment
11. Proposed Regulatory Uniformity to Boost Venture Capital Investments in Healthcare Arena, Says Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... 2017   BioLife Solutions , Inc. (NASDAQ: ... clinical grade cell and tissue hypothermic storage and ... Rice , President and CEO, will be presenting at two ... & Renshaw 19 th Annual Global Investment Conference on ... Pacific time). The conference is being held at the New ...
(Date:9/6/2017)... , Sept. 6, 2017  Medical professionals ... and skills while treating their patients. Medical ... experience without involving patients. Simulation provides a ... can carry out procedures, refine techniques and ... Integration of new technology, such as augmented ...
(Date:9/6/2017)... -- NeuroRx, a clinical stage biopharma company developing the first ... been granted Fast Track status by the US Food and ... followed by NRX-101 (D-cycloserine + lurasidone). The company will shortly ... therapy targeting patients who are admitted to Emergency Departments with ... ...
Breaking Medicine Technology:
(Date:9/20/2017)... ... September 20, 2017 , ... Demand generation pioneer ... East-coast edition of MarTech: The Marketing Tech Conference October 2–4, at the Hynes ... 40 speakers — representing such thought-leading companies as JP Morgan Chase, GE ...
(Date:9/20/2017)... ... September 20, 2017 , ... Compliancy ... industry-leading compliance software, The Guard®, has helped another long-time client pass their Department ... and properly satisfy the law. , Thanks to the help of the Compliancy ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... campaign, “Humans With Vaginas.” The goal is to ignite conversation via social media ... care products. The brand has declared September “Humans with Vaginas” month, releasing a ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... millions of older Americans at risk of price gouging for their prescription drugs, ... League (TSCL) . “Because Medicare isn’t negotiating on our behalf, there’s no consistency ...
(Date:9/20/2017)... ... ... “The Trials I Face to Receive God’s Grace”: a mesmerizing take on one ... better one’s life through God. “The Trials I Face to Receive God’s Grace” is ... found a love for writing. Green feels that expressing his feelings through prayer will ...
Breaking Medicine News(10 mins):